Richard Cathomas
Patient and General Population Preferences Regarding the Benefits and Harms of Treatment for Metastatic Prostate Cancer: A Discrete Choice Experiment.
Menges D, Piatti M, Omlin A, Cathomas R, Benamran D, Fischer S, Iselin C, Kueng M, Lorch A, Prause L, Rothermundt C, O'Meara Stern A, Zihler D, Lippuner M, Braun J, Cerny T, Puhan M. Patient and General Population Preferences Regarding the Benefits and Harms of Treatment for Metastatic Prostate Cancer: A Discrete Choice Experiment. Eur Urol Open Sci 2023; 51:26-38.
22.03.2023Patient and General Population Preferences Regarding the Benefits and Harms of Treatment for Metastatic Prostate Cancer: A Discrete Choice Experiment.
22.03.2023Eur Urol Open Sci 2023; 51:26-38
Menges Dominik, Piatti Michela C, Omlin Aurelius, Cathomas Richard, Benamran Daniel, Fischer Stefanie, Iselin Christophe E, Kueng Marc, Lorch Anja, Prause Lukas, Rothermundt Christian, O'Meara Stern Alix, Zihler Deborah, Lippuner Max, Braun Julia, Cerny Thomas, Puhan Milo Alan
Impact of differing methodologies for serum miRNA-371a-3p assessment in stage I testicular germ cell cancer recurrence.
Christiansen A, Lobo J, Fankhauser C, Rothermundt C, Cathomas R, Batavia A, Grogg J, Templeton A, Hirschi-Blickenstorfer A, Lorch A, Gillessen S, Moch H, Beyer J, Hermanns T. Impact of differing methodologies for serum miRNA-371a-3p assessment in stage I testicular germ cell cancer recurrence. Front Oncol 2022; 12:1056823.
08.12.2022Impact of differing methodologies for serum miRNA-371a-3p assessment in stage I testicular germ cell cancer recurrence.
08.12.2022Front Oncol 2022; 12:1056823
Christiansen Ailsa J, Lobo João, Fankhauser Christian D, Rothermundt Christian, Cathomas Richard, Batavia Aashil A, Grogg Josias B, Templeton Arnoud J, Hirschi-Blickenstorfer Anita, Lorch Anja, Gillessen Silke, Moch Holger, Beyer Jörg, Hermanns Thomas
Treatment Outcomes for Men with Clinical Stage II Nonseminomatous Germ Cell Tumours Treated with Primary Retroperitoneal Lymph Node Dissection: A Systematic Review.
Neuenschwander A, Lonati C, Antonelli L, Papachristofilou A, Cathomas R, Rothermundt C, Templeton A, Gulamhusein A, Fischer S, Gillessen S, Hermanns T, Lorch A, Mattei A, Fankhauser C. Treatment Outcomes for Men with Clinical Stage II Nonseminomatous Germ Cell Tumours Treated with Primary Retroperitoneal Lymph Node Dissection: A Systematic Review. Eur Urol Focus 2022
12.11.2022Treatment Outcomes for Men with Clinical Stage II Nonseminomatous Germ Cell Tumours Treated with Primary Retroperitoneal Lymph Node Dissection: A Systematic Review.
12.11.2022Eur Urol Focus 2022
Neuenschwander Anne, Lonati Chiara, Antonelli Luca, Papachristofilou Alexandros, Cathomas Richard, Rothermundt Christian, Templeton Arnoud J, Gulamhusein Aziz, Fischer Stefanie, Gillessen Silke, Hermanns Thomas, Lorch Anja, Mattei Agostino, Fankhauser Christian D
Single-dose carboplatin followed by involved-node radiotherapy for stage IIA and stage IIB seminoma (SAKK 01/10): a single-arm, multicentre, phase 2 trial.
Papachristofilou A, Bedke J, Hayoz S, Schratzenstaller U, Pless M, Hentrich M, Krege S, Lorch A, Aebersold D, Putora P, Berthold D, Zihler D, Zengerling F, Dieing A, Mueller A, Schaer C, Biaggi C, Gillessen S, Cathomas R. Single-dose carboplatin followed by involved-node radiotherapy for stage IIA and stage IIB seminoma (SAKK 01/10): a single-arm, multicentre, phase 2 trial. Lancet Oncol 2022; 23:1441-1450.
10.10.2022Single-dose carboplatin followed by involved-node radiotherapy for stage IIA and stage IIB seminoma (SAKK 01/10): a single-arm, multicentre, phase 2 trial.
10.10.2022Lancet Oncol 2022; 23:1441-1450
Papachristofilou Alexandros, Bedke Jens, Hayoz Stefanie, Schratzenstaller Ulrich, Pless Miklos, Hentrich Marcus, Krege Susanne, Lorch Anja, Aebersold Daniel-M, Putora Paul Martin, Berthold Dominik-R, Zihler Deborah, Zengerling Friedemann, Dieing Annette, Mueller Arndt-Christian, Schaer Corinne, Biaggi Christine, Gillessen Silke, Cathomas Richard
Metastatic Potential of Small Testicular Germ Cell Tumors: Implications for Surveillance of Small Testicular Masses.
Pratsinis M, Fankhauser C, Pratsinis K, Beyer J, Bührer E, Cathomas R, Fischer N, Hermanns T, Hirschi-Blickenstorfer A, Kamradt J, Alex Kluth L, Zihler D, Mingrone W, Müller B, Nestler T, Rothschild S, Seifert B, Templeton A, Terbuch A, Ufen M, Woelky R, Gillessen S, Rothermundt C. Metastatic Potential of Small Testicular Germ Cell Tumors: Implications for Surveillance of Small Testicular Masses. Eur Urol Open Sci 2022; 40:16-18.
26.04.2022Metastatic Potential of Small Testicular Germ Cell Tumors: Implications for Surveillance of Small Testicular Masses.
26.04.2022Eur Urol Open Sci 2022; 40:16-18
Pratsinis Manolis, Fankhauser Christian, Pratsinis Katerina, Beyer Jörg, Bührer Emanuel, Cathomas Richard, Fischer Natalie, Hermanns Thomas, Hirschi-Blickenstorfer Anita, Kamradt Jörn, Alex Kluth Luis, Zihler Deborah, Mingrone Walter, Müller Beat, Nestler Tim, Rothschild Sacha I, Seifert Bettina, Templeton Arnoud J, Terbuch Angelika, Ufen Mark-Peter, Woelky Regina, Gillessen Silke, Rothermundt Christian
Detection of recurrences using serum miR-371a-3p during active surveillance in men with stage I testicular germ cell tumours.
Fankhauser C, Christiansen A, Rothermundt C, Cathomas R, Wettstein M, Grossmann N, Grogg J, Templeton A, Hirschi-Blickenstorfer A, Lorch A, Gillessen S, Moch H, Beyer J, Hermanns T. Detection of recurrences using serum miR-371a-3p during active surveillance in men with stage I testicular germ cell tumours. Br J Cancer 2021; 126:1140-1144.
15.12.2021Detection of recurrences using serum miR-371a-3p during active surveillance in men with stage I testicular germ cell tumours.
15.12.2021Br J Cancer 2021; 126:1140-1144
Fankhauser Christian D, Christiansen Ailsa J, Rothermundt Christian, Cathomas Richard, Wettstein Marian S, Grossmann Nico C, Grogg Josias B, Templeton Arnoud J, Hirschi-Blickenstorfer Anita, Lorch Anja, Gillessen Silke, Moch Holger, Beyer Joerg, Hermanns Thomas
Swiss germ-cell cancer consensus recommendations
Beyer J, Stenner F, Spahn M, Seiler R, Rothermundt C, Roth B, Papachristofilou A, Omlin A, Lorch A, Honecker F, Hermanns T, Gross T, Gillessen S, Fischer S, Fankhauser C, Cathomas R, Bode P, Berthold D, Bührer E. Swiss germ-cell cancer consensus recommendations. Swiss Med Wkly 2021; 151
23.08.2021Swiss germ-cell cancer consensus recommendations
23.08.2021Swiss Med Wkly 2021; 151
Beyer Jörg, Stenner Frank, Spahn Martin, Seiler Roland, Rothermundt Christian, Roth Beat, Papachristofilou Alexandros, Omlin Aurelius, Lorch Anja, Honecker Friedemann, Hermanns Thomas, Gross Tobias, Gillessen Silke, Fischer Stefanie, Fankhauser Christian D, Cathomas Richard, Bode Peter-Karl, Berthold Dominik, Bührer Emanuel
SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non-Small-Cell Lung Cancer-A Multicenter Single-Arm Phase II Trial
Rothschild S, Cathomas R, Ochsenbein A, Janthur W, Waibel C, Mach N, Froesch P, Buess M, Bohanes P, Godar G, Rusterholz C, Gonzalez M, Pless M, Mark M, Peters S, Zippelius A, Eboulet E, Savic Prince S, Betticher D, Bettini A, Früh M, Jörger M, Lardinois D, Gelpke H, Mauti L, Britschgi C, Weder W, Swiss Group for Clinical Cancer Research (SAKK). SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non-Small-Cell Lung Cancer-A Multicenter Single-Arm Phase II Trial. J Clin Oncol 2021; 39:2872-2880.
12.07.2021SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non-Small-Cell Lung Cancer-A Multicenter Single-Arm Phase II Trial
12.07.2021J Clin Oncol 2021; 39:2872-2880
Rothschild Sacha I, Cathomas Richard, Ochsenbein Adrian F, Janthur Wolf-Dieter, Waibel Christine, Mach Nicolas, Froesch Patrizia, Buess Martin, Bohanes Pierre, Godar Gilles, Rusterholz Corinne, Gonzalez Michel, Pless Miklos, Mark Michael, Peters Solange, Zippelius Alfred, Eboulet Eric I, Savic Prince Spasenija, Betticher Daniel, Bettini Adrienne, Früh Martin, Jörger Markus, Lardinois Didier, Gelpke Hans, Mauti Laetitia A, Britschgi Christian, Weder Walter, Swiss Group for Clinical Cancer Research (SAKK)
Patterns of care and economic consequences of using bone-targeted agents for castration-sensitive prostate cancer patients with bone metastases to prevent skeletal-related events in Switzerland - the SAKK 95/16 prostate study
Stoffel S, Lupatsch J, Schwenkglenks M, Dietrich D, Schär C, Feller A, Anchisi S, von Briel T, Zürrer-Härdi U, Gillessen S, Cathomas R, Thürlimann B, von Moos R, Mark M. Patterns of care and economic consequences of using bone-targeted agents for castration-sensitive prostate cancer patients with bone metastases to prevent skeletal-related events in Switzerland - the SAKK 95/16 prostate study. Swiss Med Wkly 2021; 151:w20464.
01.03.2021Patterns of care and economic consequences of using bone-targeted agents for castration-sensitive prostate cancer patients with bone metastases to prevent skeletal-related events in Switzerland - the SAKK 95/16 prostate study
01.03.2021Swiss Med Wkly 2021; 151:w20464
Stoffel Sandro Tiziano, Lupatsch Judith E, Schwenkglenks Matthias, Dietrich Daniel, Schär Corinne, Feller Anita, Anchisi Sandro, von Briel Thomas, Zürrer-Härdi Ursina, Gillessen Silke, Cathomas Richard, Thürlimann Beat, von Moos Roger, Mark Michael Thomas
Quality of life and pain in patients with metastatic bone disease from solid tumors treated with bone-targeted agents- a real-world cross-sectional study from Switzerland (SAKK 95/16)
Ribi K, von Moos R, Caspar C, Mannhart M, von Burg P, Blum V, Bohanes P, Anchisi S, von Briel T, Zürrer-Härdi U, Cathomas R, Dietrich D, Schär C, Thürlimann B, Mark M. Quality of life and pain in patients with metastatic bone disease from solid tumors treated with bone-targeted agents- a real-world cross-sectional study from Switzerland (SAKK 95/16). BMC cancer 2021; 21:182.
19.02.2021Quality of life and pain in patients with metastatic bone disease from solid tumors treated with bone-targeted agents- a real-world cross-sectional study from Switzerland (SAKK 95/16)
19.02.2021BMC cancer 2021; 21:182
Ribi Karin, von Moos Roger, Caspar Clemens B, Mannhart Meinrad, von Burg Philippe, Blum Veronika, Bohanes Pierre, Anchisi Sandro, von Briel Thomas, Zürrer-Härdi Ursina, Cathomas Richard, Dietrich Daniel, Schär Corinne, Thürlimann Beat, Mark Michael
Patterns of care for patients with metastatic bone disease in solid tumors: A cross-sectional study from Switzerland (SAKK 95/16)
Mark M, Caspar C, Mannhart M, von Burg P, Blum V, Bohanes P, Anchisi S, von Briel T, Zürrer-Härdi U, Cathomas R, Dietrich D, Schär C, Ribi K, Thürlimann B, von Moos R. Patterns of care for patients with metastatic bone disease in solid tumors: A cross-sectional study from Switzerland (SAKK 95/16). J Bone Oncol 2019; 21:100273.
16.12.2019Patterns of care for patients with metastatic bone disease in solid tumors: A cross-sectional study from Switzerland (SAKK 95/16)
16.12.2019J Bone Oncol 2019; 21:100273
Mark Michael, Caspar Clemens B, Mannhart Meinrad, von Burg Philipp, Blum Veronika, Bohanes Pierre, Anchisi Sandro, von Briel Thomas, Zürrer-Härdi Ursina, Cathomas Richard, Dietrich Daniel, Schär Corinne, Ribi Karin, Thürlimann Beat, von Moos Roger
EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort: Under the Auspices of the EAU-ESMO Guidelines Committees
Khoo V, N'Dow J, Necchi A, Neuzillet Y, Oddens J, Oldenburg J, Osanto S, J G Oyen W, Pacheco-Figueiredo L, Pappot H, Patel M, Pieters B, Plass K, Remzi M, Müller C, Müller A, Kiltie A, Krege S, Ladoire S, Lara P, Leliveld A, Linares-Espinós E, Løgager V, Lorch A, Loriot Y, Meijer R, Mir M, Moschini M, Mostafid H, Retz M, Richenberg J, Turkbey B, Lauridsen S, Valdagni R, Der Heijden A, Van Poppel H, Vartolomei M, Veskimäe E, Vilaseca A, Rivera F, Wiegel T, Wiklund P, Williams A, Zigeuner R, Tombal B, Thalmann G, Rink M, Roghmann F, Rosenberg J, Rouprêt M, Rouvière O, Salembier C, Salminen A, Sargos P, Sengupta S, Sherif A, Smeenk R, Smits A, Stenzl A, Horwich A, Kamat A, Witjes J, Arends T, Bamias A, Birtle A, Black P, Bochner B, Bolla M, Boormans J, Bossi A, Briganti A, Brummelhuis I, Burger M, Castellano D, Cathomas R, Agarwal N, Xylinas E, Babjuk M, Bellmunt J, Bruins H, de Reijke T, De Santis M, Gillessen Sommer S, James N, MacLennan S, Palou J, Powles T, Ribal M, Shariat S, Der Kwast T, Chiti A, Choudhury A, Gontero P, Grubmüller B, Hafeez S, Hansel D, Hartmann A, Hayne D, Henry A, Hernandez V, Herr H, Herrmann K, Hoskin P, Huguet J, Jereczek-Fossa B, Geavlete B, Gakis G, Compérat E, Crabb S, Culine S, De Bari B, De Blok W, J L De Visschere P, Decaestecker K, Dimitropoulos K, Dominguez-Escrig J, Fanti S, Fonteyne V, Frydenberg M, Futterer J, Jones R. EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort: Under the Auspices of the EAU-ESMO Guidelines Committees. Eur Urol 2019; 77:223-250.
19.11.2019EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort: Under the Auspices of the EAU-ESMO Guidelines Committees
19.11.2019Eur Urol 2019; 77:223-250
Khoo Vincent, N'Dow James, Necchi Andrea, Neuzillet Yann, Oddens Jorg R, Oldenburg Jan, Osanto Susanne, J G Oyen Wim, Pacheco-Figueiredo Luís, Pappot Helle, Patel Manish I, Pieters Bradley R, Plass Karin, Remzi Mesut, Müller Christoph R, Müller Arndt-Christian, Kiltie Anne E, Krege Susanne, Ladoire Sylvain, Lara Pedro C, Leliveld Annemarie, Linares-Espinós Estefania, Løgager Vibeke, Lorch Anja, Loriot Yohann, Meijer Richard, Mir M Carmen, Moschini Marco, Mostafid Hugh, Retz Margitta, Richenberg Jonathan, Turkbey Baris, Lauridsen Susanne Vahr, Valdagni Riccardo, Der Heijden Antoine G Van, Van Poppel Hein, Vartolomei Mihai D, Veskimäe Erik, Vilaseca Antoni, Rivera Franklin A Vives, Wiegel Thomas, Wiklund Peter, Williams Andrew, Zigeuner Richard, Tombal Bertrand, Thalmann George N, Rink Michael, Roghmann Florian, Rosenberg Jonathan E, Rouprêt Morgan, Rouvière Olivier, Salembier Carl, Salminen Antti, Sargos Paul, Sengupta Shomik, Sherif Amir, Smeenk Robert J, Smits Anita, Stenzl Arnulf, Horwich Alan, Kamat Ashish M, Witjes J Alfred, Arends Tom, Bamias Aristotle, Birtle Alison, Black Peter C, Bochner Bernard H, Bolla Michel, Boormans Joost L, Bossi Alberto, Briganti Alberto, Brummelhuis Iris, Burger Max, Castellano Daniel, Cathomas Richard, Agarwal Neeraj, Xylinas Evanguelos, Babjuk Marek, Bellmunt Joaquim, Bruins H Maxim, de Reijke Theo M, De Santis Maria, Gillessen Sommer Silke, James Nicholas, MacLennan Steven, Palou Juan, Powles Tom, Ribal Maria J, Shariat Shahrokh F, Der Kwast Theo Van, Chiti Arturo, Choudhury Ananya, Gontero Paolo, Grubmüller Bernhard, Hafeez Shaista, Hansel Donna E, Hartmann Arndt, Hayne Dickon, Henry Ann M, Hernandez Virginia, Herr Harry, Herrmann Ken, Hoskin Peter, Huguet Jorge, Jereczek-Fossa Barbara A, Geavlete Bogdan, Gakis Georgios, Compérat Eva, Crabb Simon, Culine Stéphane, De Bari Berardino, De Blok Willem, J L De Visschere Pieter, Decaestecker Karel, Dimitropoulos Konstantinos, Dominguez-Escrig Jose L, Fanti Stefano, Fonteyne Valerie, Frydenberg Mark, Futterer Jurgen J, Jones Rob
Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression: a phase 1 dose-escalation and dose-expansion study
Schuler M, Gajate P, Cathomas R, Rajagopalan P, Grevel J, Bender S, Boix O, Nogai H, Ocker M, Ellinghaus P, Schostak M, Park S, Cho B, Sayehli C, Navarro A, Soo R, Richly H, Cassier P, Tai D, Penel N, Nogova L, Jörger M. Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression: a phase 1 dose-escalation and dose-expansion study. Lancet Oncol 2019
09.08.2019Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression: a phase 1 dose-escalation and dose-expansion study
09.08.2019Lancet Oncol 2019
Schuler Martin, Gajate Pablo, Cathomas Richard, Rajagopalan Prabhu, Grevel Joachim, Bender Sebastian, Boix Oliver, Nogai Hendrik, Ocker Matthias, Ellinghaus Peter, Schostak Martin, Park Se Hoon, Cho Byoung Chul, Sayehli Cyrus Michael, Navarro Alejandro, Soo Ross A, Richly Heike, Cassier Philippe Alexandre, Tai David, Penel Nicolas, Nogova Lucia, Jörger Markus
Analysis of AR/ARV7 Expression in Isolated Circulating Tumor Cells of Patients with Metastatic Castration-Resistant Prostate Cancer (SAKK 08/14 IMPROVE Trial)
Hench I, Vlajnic T, Bubendorf L, Burg P, Tolnay M, Ruiz C, Rothermundt C, Püschel H, Mestre R, Mingrone W, Kremer E, Hermanns T, Hench J, Gillessen Sommer S, Fischer N, Costa L, Cathomas R, Sakk S. Analysis of AR/ARV7 Expression in Isolated Circulating Tumor Cells of Patients with Metastatic Castration-Resistant Prostate Cancer (SAKK 08/14 IMPROVE Trial). Cancers (Basel) 2019; 11
01.08.2019Analysis of AR/ARV7 Expression in Isolated Circulating Tumor Cells of Patients with Metastatic Castration-Resistant Prostate Cancer (SAKK 08/14 IMPROVE Trial)
01.08.2019Cancers (Basel) 2019; 11
Hench Ivana Bratic, Vlajnic Tatjana, Bubendorf Lukas, Burg Philippe Von, Tolnay Markus, Ruiz Christian, Rothermundt Christian, Püschel Heike, Mestre Ricardo Pereira, Mingrone Walter, Kremer Eloïse, Hermanns Thomas, Hench Jürgen, Gillessen Sommer Silke, Fischer Natalie, Costa Luigi, Cathomas Richard, Sakk Swiss Group For Clinical Cancer Research
Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study
Dieckmann K, Heinzelbecker J, Heidenreich A, Cremers J, Oing C, Hermanns T, Fankhauser C, Gillessen Sommer S, Reichegger H, Cathomas R, Pichler M, Hentrich M, Eredics K, Lorch A, Wülfing C, Peine S, Wosniok W, Bokemeyer C, Ruf C, Loidl W, Haben B, Radtke A, Geczi L, Matthies C, Anheuser P, Eckardt U, Sommer J, Zengerling F, Trenti E, Pichler R, Belz H, Zastrow S, Winter A, Melchior S, Hammel J, Kranz J, Bolten M, Krege S, Belge G. Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study. J Clin Oncol 2019; 37:1412-1423.
15.03.2019Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study
15.03.2019J Clin Oncol 2019; 37:1412-1423
Dieckmann Klaus-Peter, Heinzelbecker Julia, Heidenreich Axel, Cremers Jann Frederik, Oing Christoph, Hermanns Thomas, Fankhauser Christian Daniel, Gillessen Sommer Silke, Reichegger Hermann, Cathomas Richard, Pichler Martin, Hentrich Marcus, Eredics Klaus, Lorch Anja, Wülfing Christian, Peine Sven, Wosniok Werner, Bokemeyer Carsten, Ruf Christian Guido, Loidl Wolfgang, Haben Björn, Radtke Arlo, Geczi Lajos, Matthies Cord, Anheuser Petra, Eckardt Ulrike, Sommer Jörg, Zengerling Friedemann, Trenti Emanuela, Pichler Renate, Belz Hanjo, Zastrow Stefan, Winter Alexander, Melchior Sebastian, Hammel Johannes, Kranz Jennifer, Bolten Marius, Krege Susanne, Belge Gazanfer
Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer
Papachristofilou A, Kallen K, Fotin-Mleczek M, Schröder A, Scheel B, Muth A, Seibel T, Stosnach C, Doener F, Hong H, Koch S, Gnad-Vogt U, Griesinger F, Geißler M, Bischoff H, Hipp M, Klinkhardt U, Früh M, Sebastian M, Weiss C, Pless M, Cathomas R, Hilbe W, Pall G, Wehler T, Alt J, Zippelius A. Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer. J Immunother Cancer 2019; 7:38.
08.02.2019Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer
08.02.2019J Immunother Cancer 2019; 7:38
Papachristofilou Alexandros, Kallen Karl-Josef, Fotin-Mleczek Mariola, Schröder Andreas, Scheel Birgit, Muth Anke, Seibel Tobias, Stosnach Claudia, Doener Fatma, Hong Henoch S, Koch Sven D, Gnad-Vogt Ulrike, Griesinger Frank, Geißler Michael, Bischoff Helge, Hipp Madeleine M, Klinkhardt Ute, Früh Martin, Sebastian Martin, Weiss Christian, Pless Miklos, Cathomas Richard, Hilbe Wolfgang, Pall Georg, Wehler Thomas, Alt Jürgen, Zippelius Alfred
Impact of Addition of Metformin to Abiraterone in Metastatic Castration-Resistant Prostate Cancer Patients With Disease Progressing While Receiving Abiraterone Treatment (MetAb-Pro): Phase 2 Pilot Study
Mark M, Strebel R, Manetsch G, Pollak M, von Moos R, Gillessen Sommer S, Rothermundt C, Winterhalder R, Mey U, Klingbiel D, Cathomas R. Impact of Addition of Metformin to Abiraterone in Metastatic Castration-Resistant Prostate Cancer Patients With Disease Progressing While Receiving Abiraterone Treatment (MetAb-Pro): Phase 2 Pilot Study. Clin Genitourin Cancer 2019
02.01.2019Impact of Addition of Metformin to Abiraterone in Metastatic Castration-Resistant Prostate Cancer Patients With Disease Progressing While Receiving Abiraterone Treatment (MetAb-Pro): Phase 2 Pilot Study
02.01.2019Clin Genitourin Cancer 2019
Mark Michael, Strebel Räto, Manetsch Gabriela, Pollak Michael, von Moos Roger, Gillessen Sommer Silke, Rothermundt Christian, Winterhalder Ralph, Mey Ulrich, Klingbiel Dirk, Cathomas Richard
Questioning the Value of Fluorodeoxyglucose Positron Emission Tomography for Residual Lesions After Chemotherapy for Metastatic Seminoma: Results of an International Global Germ Cell Cancer Group Registry
Cathomas R, Gillessen Sommer S, Fankhauser C, Hentrich M, Haugnes H, Oing C, Fedyanin M, De Giorgi U, Morelli F, Garcia Del Muro X, Lorch A, Bernard B, Klingbiel D, Beyer J. Questioning the Value of Fluorodeoxyglucose Positron Emission Tomography for Residual Lesions After Chemotherapy for Metastatic Seminoma: Results of an International Global Germ Cell Cancer Group Registry. J Clin Oncol 2018:JCO1800210.
04.10.2018Questioning the Value of Fluorodeoxyglucose Positron Emission Tomography for Residual Lesions After Chemotherapy for Metastatic Seminoma: Results of an International Global Germ Cell Cancer Group Registry
04.10.2018J Clin Oncol 2018:JCO1800210
Cathomas Richard, Gillessen Sommer Silke, Fankhauser Christian, Hentrich Marcus, Haugnes Hege Sagstuen, Oing Christoph, Fedyanin Mikhail, De Giorgi Ugo, Morelli Franco, Garcia Del Muro Xavier, Lorch Anja, Bernard Brandon, Klingbiel Dirk, Beyer Jörg
[Treatment of Advanced Prostate Carcinoma - an Interdisciplinary Recommendation]
Omlin A, Zwahlen D, Wyler S, Wild D, Templeton A, Stenner F, Schmid H, Roggero E, Rentsch C, Nitzsche E, Kueng M, Jochum W, Gillessen Sommer S, Eberli D, Beyer J, Spahn M, Cathomas R. [Treatment of Advanced Prostate Carcinoma - an Interdisciplinary Recommendation]. Praxis (Bern 1994) 2018; 107:1043-1051.
01.09.2018[Treatment of Advanced Prostate Carcinoma - an Interdisciplinary Recommendation]
01.09.2018Praxis (Bern 1994) 2018; 107:1043-1051
Omlin Aurelius, Zwahlen Daniel, Wyler Stephen, Wild Damian, Templeton Arnoud J, Stenner Frank, Schmid Hans-Peter, Roggero Enrico, Rentsch Cyrill A, Nitzsche Egbert, Kueng Marc, Jochum Wolfram, Gillessen Sommer Silke, Eberli Daniel, Beyer Jörg, Spahn Martin, Cathomas Richard
Correction to: Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS)
Rothermundt C, Woelky R, Fankhauser C, Kunit T, Fischer N, Inauen R, Kamradt J, Ziegler K, Haynes A, Jüni P, Grassmugg T, Terbuch A, Thurneisen C, Cathomas R, Müller B, Mingrone W, Hirschi-Blickenstorfer A, Wehrhahn T, Ruf C, Rothschild S, Seifert B, Gillessen Sommer S. Correction to: Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS). Swiss Med Wkly 2018; 148:w14674.
29.08.2018Correction to: Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS)
29.08.2018Swiss Med Wkly 2018; 148:w14674
Rothermundt Christian, Woelky Regina, Fankhauser Christian, Kunit Thomas, Fischer Natalie, Inauen Roman, Kamradt Jörn, Ziegler Katrin, Haynes Alan, Jüni Peter, Grassmugg Thomas, Terbuch Angelika, Thurneisen Claudio, Cathomas Richard, Müller Beat, Mingrone Walter, Hirschi-Blickenstorfer Anita, Wehrhahn Tobias, Ruf Christian, Rothschild Sacha I, Seifert Bettina, Gillessen Sommer Silke